Diagnostic and pathogenetic significance of increased stromal apoptosis and incomplete vasculogenesis in complete hydatidiform moles in very early pregnancy periods

American Journal of Surgical Pathology

Volumn 30, Issue 3, 2006, Pages 362-369

  Kim, Mi Jung ^a   Kim, Kyu Rae ^a   Ro, Jae Y ^b   Lage, Janice M ^c   Lee, Hyang Im ^a  

^a University of Ulsan College of Medicine   (South Korea)

^b Department of Obstetrics Gynecology   (United States)

^c MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

Author keywords

Apoptosis; Blood vessels; Caspase; Hydatidiform mole; Ki 67; Stroma

Indexed keywords

CASPASE 3; CD31 ANTIGEN; KI 67 ANTIGEN;

ANGIOGENESIS; APOPTOSIS; ARTICLE; CELL DIFFERENTIATION; CELL PROLIFERATION; CHORION VILLUS; CONTROLLED STUDY; DIFFERENTIAL DIAGNOSIS; EARLY DIAGNOSIS; FEMALE; FIRST TRIMESTER PREGNANCY; HUMAN; HUMAN TISSUE; HYDATIDIFORM MOLE; IMMUNOHISTOCHEMISTRY; PATHOGENESIS; PLACENTA; STROMA CELL; COMPARATIVE STUDY; METABOLISM; PATHOLOGY; PHYSIOLOGY; PREGNANCY; UTERUS CANCER; VASCULARIZATION;

ANTIGENS, CD31; APOPTOSIS; CELL PROLIFERATION; DIAGNOSIS, DIFFERENTIAL; FEMALE; HUMANS; HYDATIDIFORM MOLE; IMMUNOHISTOCHEMISTRY; PLACENTA; PREGNANCY; STROMAL CELLS; UTERINE NEOPLASMS;

EID: 33645957652     PISSN: 01475185     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.pas.0000194299.27463.21     Document Type: Article

References (30)

1. Castrillon DH, Sun D, Weremowicz S, et al. Discrimination of complete hydatidiform mole from its mimics by immunohistochemistry of the paternally imprinted gene product p57KIP2. Am J Surg Pathol. 2001;25:1225-1230.
2. Chilosi M, Piazzola E, Lestani M, et al. Differential expression of p57kip2, a maternally imprinted cdk inhibitor, in normal human placenta and gestational trophoblastic disease. Lab Invest. 1998;78:269-276.
3. Chiu PM, Ngan YS, Khoo US, et al. Apoptotic activity in gestational trophoblastic disease correlates with clinical outcome: assessment by the caspase-related M30 CytoDeath antibody. Histopathology. 2001;38:243-249.
4. Demir R, Kaufmann P, Castellucci M, et al. Fetal vasculogenesis and angiogenesis in human placental villi. Acta Anat (Basel). 1989;136:190-203.
5. Fukunaga M, Katabuchi H, Nagasaka T, et al. Interobserver and intraobserver variability in the diagnosis of hydatidiform mole. Am J Surg Pathol. 2005;29:942-947.
6. Halperin R, Peller S, Sandbank J, et al. Expression of the p53 gene and apoptosis in gestational trophoblastic disease. Placenta. 2000;21:58-62.
7. Harma M, Kocyigit A, Yurtseven S, et al. Serum levels of folate, vitamin B12 and homocysteine in complete hydatidiform mole. J Reprod Med. 2004;49:285-288.
8. Jun SY, Ro JY, Kim KR. p57kip2 is useful in the classification and differential diagnosis of complete and partial hydatidiform moles. Histopathology. 2003;43:17-25.
9. Keep D, Zaragoza MV, Hassold T, et al. Very early complete hydatidiform mole. Hum Pathol. 1996;27:708-713.
10. Lage JM, Mark SD, Roberts DJ, et al. A flow cytometric study of 137 fresh hydropic placentas: correlation between types of hydatidiform moles and nuclear DNA ploidy. Obstet Gynecol. 1992;79:403-410.
11. Lage JM, Young RH. Pathology of trophoblastic disease. In: Clement PB, Young YH, eds. Tumors and Tumorlike Lesions of the Uterine Corpus and Cervix. New York: Churchill Livingstone; 1993:419-475.
12. Lisman BA, Boer K, Bleker OP, et al. Vasculogenesis in complete and partial hydatidiform mole pregnancies studied with CD34 immunohistochemistry. Hum Reprod. 2005;20:2334-2339.
13. Merchant SH, Amin MB, Viswanatha DS, et al. p57KIP2 immunohistochemistry in early molar pregnancies: emphasis on its complementary role in the differential diagnosis of hydropic abortuses. Hum Pathol. 2005;36:180-186.
14. Mosher R, Goldstein DP, Berkowitz R, et al. Complete hydatidiform mole: comparison of clinicopathologic features, current and past. J Reprod Med. 1998;43:21-27.
15. Pongcharoen S, Searle RF, Bulmer JN. Placental Fas and Fas ligand expression in normal early, term and molar pregnancy. Placenta. 2004;25:321-330.
16. Qiao S, Nagasaka T, Harada T, et al. p53, Bax and Bcl-2 expression, and apoptosis in gestational trophoblast of complete hydatidiform mole. Placenta. 1998;19:361-369.
17. Qiao S, Nagasaka T, Nakashima N. Numerous vessels detected by CD34 in the villous stroma of complete hydatidiform moles. Int J Gynecol Pathol. 1997;16:233-238.
18. Reynolds SR. Hydatidiform mole: a vascular congenital anomaly. Obstet Gynecol. 1976;47:244-250.
19. Sebire NJ, Fisher RA, Rees HC. Histopathological diagnosis of partial and complete hydatidiform mole in the first trimester of pregnancy. Pediatr Dev Pathol. 2002;6:69-77.
20. Sebire NJ, Rees H, Paradinas F, et al. The diagnostic implications of routine ultrasound examination in histologically confirmed early molar pregnancies. Ultrasound Obstet Gynecol. 2001;18:662-665.
21. Shih I-M, Mazur MT, Kurman RJ. Gestational trophoblastic disease and related lesions. In: Kurman RJ, ed. Blaustein's Pathology of the Female Genital Tract. New York: Springer; 2002:1193-1247.
22. Silverberg SG, Kurman RJ. Classification and pathology of gestational trophoblastic disease. In: Silverberg SG, Kurman RJ, eds. Tumors of the Uterine Corpus and Gestational Trophoblastic Disease. Washington, DC: Armed Forces Institute of Pathology; 1992:233-282.
23. Soto-Wright V, Bernstein M, Goldstein DP, et al. The changing clinical presentation of complete molar pregnancy. Obstet Gynecol. 1995;86:775-779.
24. Szulman AE, Surti U. The syndromes of hydatidiform mole: II. Morphologic evolution of the complete and partial mole. Am J Obstet Gynecol. 1978; 132:20-27.
25. Thaker HM, Berlin A, Tycko B, et al. Immunohistochemistry for the imprinted gene product IPL/PHLDA2 for facilitating the differential diagnosis of complete hydatidiform mole. J Reprod Med. 2004;49:630-636.
26. Wong SY, Ngan HY, Chan CC, et al. Apoptosis in gestational trophoblastic disease is correlated with clinical outcome and Bcl-2 expression but not Bax expression. Mod Pathol. 1999;12:1025-1033.
27. Yoshida K, Nagasaka T, Nakashima N, et al. Elucidation of vascular structure of molar villi in complete hydatidiform mole by CD-34 antibody. Int J Gynecol Pathol. 2000;19:212-218.
28. Zhang P, Liegeois NJ, Wong C, et al. Altered cell differentiation and proliferation in mice lacking p57KIP2 indicates a role in Beckwith-Wiedemann syndrome. Nature. 1997;387:151-158.
29. Zhang P, Wong C, DePinho RA, et al. Cooperation between the Cdk inhibitors p27(KIP1) and p57(KIP2) in the control of tissue growth and development. Genes Dev. 1998;12:3162-3167.
30. Zhang P, Wong C, Liu D, et al. p21(CIP1) and p57(KIP2) control muscle differentiation at the myogenin step. Genes Dev. 1999;13:213-224.